Figure 4.
Prognostic value of LDH changes after bridging therapy among all evaluable patients (N = 157). (A) Sankey diagram depicting preleukapheresis (prebridging therapy) and preinfusion (postbridging therapy) LDH (high vs normal for each). (B) PFS and (C) OS stratified by LDH category.